Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 150 of 203 entries
View as:

Iron Replacement to Reduce Anemia During Neoadjuvant Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT05800600 Org: User:
Start: 03/15/23 End: 02/01/27 Due: 02/01/28

Irinotecan-Eluting Beads in Treating Patients With Refractory Metastatic Colon or Rectal Cancer That Has Spread to the Liver

Phase: N/A Priority: Normal
NCT ID: NCT02110953 Org: User:
Start: 01/29/16 End: 08/16/17 Due: 08/16/18

Paclitaxel and Estramustine in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00021372 Org: User:
Start: 02/29/96 End: 09/30/06 Due: 09/30/07

A Study of Pembrolizumab in Combination With Epacadostat in Women With Recurrent/Metastatic Endometrial Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT03310567 Org: User:
Start: 09/30/18 End: 09/10/18 Due: 09/10/19

Dose Dense MVAC for Muscle Invasive Bladder Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01031420 Org: User:
Start: 12/07/09 End: 08/07/13 Due: 08/07/14

Celecoxib and Rosiglitazone in Treating Patients Who Are Undergoing Cystoscopic Surveillance for Early-Stage Noninvasive Carcinoma of the Bladder or Radical Cystectomy for Muscle-Invasive Carcinoma of the Bladder

Phase: N/A Priority: Normal
NCT ID: NCT00084578 Org: User:
Start: 03/31/04 End: 04/30/06 Due: 04/30/07

Brigatinib in Relapsed or Refractory ALK-Positive Anaplastic Large Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT03719898 Org: User:
Start: 12/06/18 End: 06/16/20 Due: 06/16/21

A Pilot Study of a Home-Based Walking Intervention for Pancreatic Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT02442323 Org: User:
Start: 08/09/13 End: 11/30/20 Due: 11/30/21

Cisplatin, Interferon Alfa, Surgery, and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma

Phase: N/A Priority: Normal
NCT ID: NCT00003263 Org: User:
Start: 08/31/96 End: 11/30/00 Due: 11/30/01

Irinotecan Plus Raltitrexed in Treating Patients With Refractory Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00003109 Org: User:
Start: 12/31/97 End: 01/31/01 Due: 01/31/02

Facilitating Participation in a Prostate Cancer Risk Assessment Program

Phase: N/A Priority: Normal
NCT ID: NCT02126319 Org: User:
Start: 10/31/98 End: 04/30/02 Due: 04/30/03

Couples' QOL in Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05636943 Org: User:
Start: 01/01/21 End: 05/30/25 Due: 05/30/26

Reducing Urban Cervical Cancer Disparities

Phase: N/A Priority: Normal
NCT ID: NCT06416150 Org: User:
Start: 08/28/24 End: 12/31/27 Due: 12/31/28

Pazopanib Hydrochloride in Treating Patients With Advanced Angiosarcoma

Phase: N/A Priority: Normal
NCT ID: NCT01462630 Org: User:
Start: 11/03/11 End: 01/12/21 Due: 01/12/22

Intensity-Modulated Radiation Therapy With or Without Decreased Radiation Dose to Erectile Tissue in Treating Patients With Stage II Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00084552 Org: User:
Start: 12/11/03 End: 05/05/16 Due: 05/05/17

Printed Education Materials in Patients Who Are Finishing Treatment for Stage I, Stage II, or Stage IIIA Breast Cancer, Colorectal Cancer, Prostate Cancer, or Chest Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00372840 Org: User:
Start: 05/31/06 End: 03/31/13 Due: 03/31/14

Study of Nivolumab and Axitinib in Patients With Advanced Renal Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT03172754 Org: User:
Start: 06/12/17 End: 10/06/25 Due: 10/06/26

A Pilot Study of Circulating Tumor DNA Adaptive Risk Maintenance Approach for Bladder Cancer (CARMA)

Phase: N/A Priority: Normal
NCT ID: NCT06050954 Org: User:
Start: 09/30/23 End: 01/31/32 Due: 01/31/33

HPV Self-sampling for Underscreened Latinas

Phase: N/A Priority: Normal
NCT ID: NCT06439706 Org: User:
Start: 10/04/23 End: 09/30/24 Due: 09/30/25

Feasibility Study on Expandion of MILs From NSCLC and SCLC Patients and Infusion With Pembrolizumab

Phase: N/A Priority: Normal
NCT ID: NCT04677361 Org: User:
Start: 10/31/21 End: 10/31/24 Due: 10/31/25

Computer-Based Survey and Communication Aid in Improving Physician-Patient Communication and Treatment Decision Making in Patients With Metastatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00244868 Org: User:
Start: 07/31/03 End: - Due: -

Risk Enabled Therapy After Initiating Neoadjuvant Chemotherapy for Bladder Cancer (RETAIN)

Phase: N/A Priority: Normal
NCT ID: NCT02710734 Org: User:
Start: 02/24/16 End: 02/28/34 Due: 02/28/35

A New Radiation Therapy Planning System in Patients Undergoing Radiation Therapy for Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00436397 Org: User:
Start: 06/30/02 End: 08/31/05 Due: 08/31/06

Computed Tomography (CT) Scans Using CT-On-Rails™ to Pinpoint the Location of the Tumor in Treating Patients With Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00084526 Org: User:
Start: 11/30/03 End: 02/28/07 Due: 02/28/08

Trial of Tasigna (Nilotinib) 400 mg Twice Daily Alone or With Gleevec (Imatinib Mesylate) 400 mg Daily for Patients With Advanced Gastrointestinal Stromal Tumor (GIST)

Phase: N/A Priority: Normal
NCT ID: NCT01089595 Org: User:
Start: 02/28/09 End: 03/31/12 Due: 03/31/13